Abstract
The management of patients on oral anticoagulation (OAC) who need to undergo surgery or invasive procedures is problematic. “Bridging” the subtherapeutic periods with either intravenous unfractionated heparin or subcutaneous treatment-dose low-molecular-weight heparin (LMWH) decreases the amount of time patients are not anticoagulated but may increase the risk of postoperative bleeding and is costly. The available literature does not provide sufficient information to allow clinicians to choose an optimal perioperative strategy. Recent studies primarily have examined the perioperative use of LMWH, and have found arterial thromboembolic rates of 0.4–1.5%. The observed incidence is greater than mathematically predicted, which may be due to a potential hypercoagulable state impacting the risk for arterial thromboembolic events. The literature suggests that major postoperative bleeding is low for invasive procedures but may be substantially higher for major surgery. Given the lack of definitive data or consensus, the decision must be based on estimates of the risks of thromboembolism and bleeding and the patient's preference. For most patients at low or moderate stroke risk, bridging will be unnecessary and may be harmful. Bridging is recommended for patients who have a high annual risk of stroke and thus have a more appreciable perioperative stroke risk. Postoperative anticoagulation must be used cautiously and patients monitored closely after major surgery due to the risk of postoperative major bleeding.
Similar content being viewed by others
References
van Dongen CJJ, van den Belt AGM, Prins MH, Lensing AWA. Fixed dose subcutaneous low-molecular-weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. The Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD001100. DOI: 10.1002/14651858.CD001100.pub2.
Mismetti P, Laporte-Simitsidis S, Tardy B, et al. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Thromb Haemost 2000;83:14–19.
Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997;336;1506–1511.
Douketis JD, Crowther MA, Cherian SS, Kearon CB. Physician preferences for perioperative anticoagulation in patients with a mechanical heart valve who are undergoing elective noncardiac surgery. Chest 1999;116:1240–1246.
Douketis JD, Crowther MA, Cherian SS. Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Can J Cardio 2000;16:326–330.
Ansell, J. Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists. Chest 2004;126:204S–233S.
Dunn AS, Turpie AGG. Perioperative management of patients on oral anticoagulants: a systematic review. Arch Intern Med 2003;163:901–908.
Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004 Sep 21;110(12):1658–1663.
Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin. Assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004;164:1319–1326.
Dunn AS, Spyropoulos AC, Sirko SP, Turpie AG. Perioperative bridging therapy with enoxaparin in patients requiring interruption of long-term oral anticoagulant therapy: a multicentre cohort study. Blood 2004;104: abstract 1761.
Spyropoulos AC, Turpie AG, Dunn AS, et al. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: Results from the REGIMEN registry. Blood 2004;104: abstract 709.
Dunn AS. Wisnivesky J, Ho W, Moore C, McGinn T, Sacks HS. Perioperative management of patients on oral anticoagulants: a decision analysis. Med Dec Making 2005;25:387–392.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dunn, A. Perioperative Management of Oral Anticoagulation: When and How to Bridge. J Thromb Thrombolysis 21, 85–89 (2006). https://doi.org/10.1007/s11239-006-5582-9
Issue Date:
DOI: https://doi.org/10.1007/s11239-006-5582-9